A Phase II, Double-blind, Randomized, Placebo-controlled, Multi-center Study to Assess Efficacy and Safety of Neu2000KWL in Patients With Acute Ischemic Stroke Receiving Endovascular Therapy

Trial Profile

A Phase II, Double-blind, Randomized, Placebo-controlled, Multi-center Study to Assess Efficacy and Safety of Neu2000KWL in Patients With Acute Ischemic Stroke Receiving Endovascular Therapy

Recruiting
Phase of Trial: Phase II

Latest Information Update: 18 Jul 2017

At a glance

  • Drugs NEU 2000 (Primary)
  • Indications Stroke
  • Focus Therapeutic Use
  • Acronyms ENIS I; SONIC
  • Sponsors GNT Pharma
  • Most Recent Events

    • 11 Jul 2017 Planned End Date changed from 1 Jul 2017 to 30 Dec 2018.
    • 11 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 30 Dec 2018.
    • 31 May 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Jun 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top